Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kriya Therapeutics
Biotech
Biotech's top money raisers: 2025
While 2024 marked the return of the biotech megaround, 2025 proved that it wasn’t just a one-year anomaly.
Gabrielle Masson
Mar 2, 2026 6:30am
Yet another CDER leadership shake-up—Chutes & Ladders
Dec 5, 2025 8:30am
Gene therapy biotech Kriya catches $313M
Aug 18, 2025 4:52pm
Kriya picks up gene therapy biotech, enters NASH space
Sep 6, 2023 8:30am
Biotech's top money raisers: 2022
Apr 11, 2023 9:19am
Kriya buys Redpin to chart gene therapy course in neurology
Nov 16, 2022 11:51am
